Loading...
XSTO
EPISb
Market cap2mUSD
Dec 05, Last price  
0.03SEK
1D
1.77%
1Q
-38.68%
Jan 2017
-99.75%
IPO
-99.94%
Name

Episurf Medical AB

Chart & Performance

D1W1MN
XSTO:EPISb chart
P/E
P/S
1.69
EPS
Div Yield, %
Shrs. gr., 5y
49.02%
Rev. gr., 5y
21.55%
Revenues
13m
+26.21%
000037,916173,0261,016,4622,405,6142,490,2484,000,0004,900,0005,000,0006,500,0006,600,00010,300,00013,000,000
Net income
-76m
L-19.83%
-540,241-2,786,253-4,458,653-15,769,779-22,856,694-32,914,421-43,974,662-61,667,464-61,093,452-57,800,000-70,600,000-64,600,000-69,500,000-77,300,000-94,800,000-76,000,000
CFO
-71m
L-15.80%
-1,998,651-3,913,785-15,045,172-20,642,962-31,659,426-38,039,032-56,096,044-61,381,599-52,300,000-59,200,000-54,100,000-59,700,000-69,500,000-84,800,000-71,400,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in the Nordic countries, Germany, the United Kingdom, and internationally. It offers Episealer Condyle Solo for the treatment of localized cartilage and underlying bone defects on the femoral condyles of the knee joint; Episealer Trochlea Solo to treat localized cartilage and underlying bone defects in the area behind the patella; and Episealer Femoral Twin for the treatment of elongated localized cartilage and underlying bone defects on the femoral condyles and in the trochlea area of the knee joint. The company also provides Episealer Talus for osteochondral lesions of the talar dome of the ankle joint; Epiguide, a surgical drill guide; and Epiguide MOS, a surgical drill guide, which is designed for use in mosaicplasty surgery for treatment of cartilage and deep underlying bone defects in the knee joint. In addition, it offers µiFidelity, an order management system, for placing and following up on order, uploading MRI scans, and consult patient's damage marking report. The company was formerly known as Diamorph Medtech AB and changed its name to Episurf Medical AB (publ) in 2010. Episurf Medical AB (publ) was incorporated in 2008 and is headquartered in Stockholm, Sweden.
IPO date
Nov 05, 2010
Employees
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT